NCT00702052 · Interventional trial
Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy
Overall registry status Completed
Phase 2
Conditions Lymphoma, Mantle- Cell
Delaware Valley sites
- Fox Chase Cancer Center Regulatory Contact · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory